|
|
USP-1163162 |
USP |
Dantrolene Related Compound A - 5-(4-nitrophenyl)-2-furaldehyde azine 50 mg |
|
1,585.33 CHF
1,723.25 €
|
|
|
|
USP-1163173 |
USP |
Dantrolene Related Compound B - 5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl)semicarbazone 50 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1163184 |
USP |
Dantrolene Related Compound C (5-(4-Nitrophenyl)furan-2-carbaldehyde) 50 mg |
|
1,572.00 CHF
1,708.76 €
|
|
|
|
USP-1164200 |
USP |
Darifenacin Hydrobromide (150 mg) ((S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide hydrobromide) 150 mg |
|
1,089.33 CHF
1,184.10 €
|
|
|
|
USP-1164211 |
USP |
Darifenacin Chiral Peak ID Mixture (25 mg) (A mixture containing darifenacin hydrobromide, (S)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide [133099-07-7], and about 1% of darifenacin R-isomer, (R)-2-{1-[2-(2,3-Dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide hydrobromide) [1092800-15-1] 25 mg |
|
764.00 CHF
830.47 €
|
|
|
|
USP-1164222 |
USP |
Darifenacin Peak ID Mixture - (A mixture consisting of Darifenacin Hydrobromide (99%), Dealkyl darifenacin (0.3%), Ketodarifenacin (0.2%), and 7-Bromo darifenacin (0.3%)) 25 mg |
|
718.67 CHF
781.19 €
|
|
|
|
USP-1164697 |
USP |
Daunorubicinone - ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) 25 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1164700 |
USP |
Daunorubicin Hydrochloride (HCl) 200 mg |
|
1,396.00 CHF
1,517.45 €
|
|
